The validation of cardiovascular risk scores for patients with type diabetes mellitus

Heart

Volumn 101, Issue 3, 2015, Pages 222-229

  Van Der Leeuw, J ^a   Van Dieren, S ^a,b   Beulens, J W J ^a   Boeing, H ^c   Spijkerman, A M W ^d   Van Der Graaf, Y ^a   Van Der A, D L ^d   Nothlings U ^e   Visseren, F L J ^a   Rutten, G E H M ^a   Moons, K G M ^a   Van Der Schouw, Y T ^a   Peelen, L M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ACADEMIC MEDICAL CENTER   (Netherlands)

^c GERMAN INSTITUTE OF HUMAN NUTRITION   (Germany)

^d NATIONAL INSTITUTE FOR PUBLIC HEALTH AND THE ENVIRONMENT   (Netherlands)

^e UNIVERSITY OF BONN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACUTE HEART INFARCTION; ARTICLE; CALIBRATION; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CEREBROVASCULAR ACCIDENT; COHORT ANALYSIS; HEART FAILURE; HIGH RISK PATIENT; HUMAN; INCIDENCE; INSTRUMENT VALIDATION; ISCHEMIC HEART DISEASE; MEASUREMENT ACCURACY; NON INSULIN DEPENDENT DIABETES MELLITUS; PREDICTIVE VALUE; QUANTITATIVE ANALYSIS; RISK ASSESSMENT; SCORING SYSTEM; SYSTEMATIC REVIEW; BIOLOGICAL MODEL; CARDIOVASCULAR DISEASES; COMPLICATION; HEALTH; RISK FACTOR;

CARDIOVASCULAR DISEASES; DIABETES MELLITUS, TYPE 2; GLOBAL HEALTH; HUMANS; MODELS, CARDIOVASCULAR; RISK ASSESSMENT; RISK FACTORS;

EID: 84920895936     PISSN: 13556037     EISSN: 1468201X     Source Type: Journal    
DOI: 10.1136/heartjnl-2014-306068     Document Type: Article

References (34)

1. Sarwar N, Gao P, Seshasai SR, et al. Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies. Lancet 2010;375:2215-22.
2. Haffner SM, Lehto S, Rönnemaa T, et al. Mortality from coronary heart disease in subjects with type 2 diabetes and in nondiabetic subjects with and without prior myocardial infarction. N Engl J Med 1998;339:229-34.
3. Howard BV, Best LG, Galloway JM, et al. Coronary heart disease risk equivalence in diabetes depends on concomitant risk factors. Diabetes Care 2006;29:391-7.
4. Paynter NP, Mazer NA, Pradhan AD, et al. Cardiovascular risk prediction in diabetic men and women using hemoglobin A1c vs diabetes as a high-risk equivalent. Arch Intern Med 2011;171:1712-18.
5. Perk J, De Backer G, Gohlke H, et al. European Guidelines on cardiovascular disease prevention in clinical practice (version 2012): The Fifth Joint Task Force of the European Society of Cardiology and Other Societies on Cardiovascular Disease Prevention in Clinical Practice. Eur Heart J 2012;33:1635-701.
6. American Diabetes Association. Standards of medical care in diabetes-2013. Diabetes Care 2013;36(Suppl 1):S11-66.
7. van Dieren S, Beulens JW, Kengne AP, et al. Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review. Heart 2012;98:360-9.
8. Stevens RJ, Kothari V, Adler AI, et al. The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56). ClinSci(Lond) 2001;101:671-9.
9. Chamnan P, Simmons RK, Sharp SJ, et al. Cardiovascular risk assessment scores for people with diabetes: a systematic review. Diabetologia 2009;52:2001-14.
10. Simmons RK, Coleman RL, Price HC, et al. Performance of the UK Prospective Diabetes Study Risk Engine and the Framingham Risk Equations in Estimating Cardiovascular Disease in the EPIC- Norfolk Cohort. Diabetes Care 2009;32:708-13.
11. van Dieren S, Peelen LM, Nothlings U, et al. External validation of the UK Prospective Diabetes Study (UKPDS) risk engine in patients with type 2 diabetes. Diabetologia 2011;54:264-70.
12. National Institute for Health and Clinical Excellence. The management of type 2 diabetes: clinical guideline 87. 2009.
13. Altman DG, Vergouwe Y, Royston P, et al. Prognosis and prognostic research: validating a prognostic model. BMJ 2009;338.
14. Moons KGM, Kengne AP, Grobbee DE, et al. Risk prediction models: II. External validation, model updating, and impact assessment. Heart 2012;98:691-8.
15. Yang X, Ma RC, So WY, et al. Development and validation of a risk score for hospitalization for heart failure in patients with Type 2 diabetes mellitus. Cardiovasc Diabetol 2008;7:9.
16. Yang X, So WY, Kong AP, et al. Development and validation of stroke risk equation for Hong Kong Chinese patients with type 2 diabetes: the Hong Kong Diabetes Registry. Diabetes Care 2007;30:65-70.
17. Kothari V, Stevens RJ, Adler AI, et al . UKPDS 60: risk of stroke in type 2 diabetes estimated by the UK Prospective Diabetes Study risk engine. Stroke 2002;33:1776-81.
18. Yudkin JS, Chaturvedi N. Developing risk stratification charts for diabetic and nondiabetic subjects. DiabetMed 1999;16:219-27.
19. Mukamal KJ, Kizer JR, Djousse L, et al. Prediction and classification of cardiovascular disease risk in older adults with diabetes. Diabetologia 2013;56:275-83.
20. Elley CR, Robinson E, Kenealy T, et al. Derivation and validation of a new cardiovascular risk score for people with type 2 diabetes: the new zealand diabetes cohort study. Diabetes Care 2010;33:1347-52.
21. Kengne AP, Patel A, Marre M, et al . Contemporary model for cardiovascular risk prediction in people with type 2 diabetes. Eur J Cardiovasc Prev Rehabil 2011;18:393-8.
22. Davis WA, Knuiman MW, Davis TM. An Australian cardiovascular risk equation for type 2 diabetes: the Fremantle Diabetes Study. InternMedJ 2010;40:286-92.
23. Cederholm J, Eeg-Olofsson K, Eliasson B, et al. Risk prediction of cardiovascular disease in type 2 diabetes: a risk equation from the Swedish National Diabetes Register. Diabetes Care 2008;31:2038-43.
24. Donnan PT, Donnelly L, New JP, et al. Derivation and validation of a prediction score for major coronary heart disease events in a U.K. type 2 diabetic population. Diabetes Care 2006;29:1231-6.
25. Yang X, So WY, Kong AP, et al. Development and validation of a total coronary heart disease risk score in type 2 diabetes mellitus. AmJCardiol 2008;101:596-601.
26. Folsom AR, Chambless LE, Duncan BB, et al. Prediction of coronary heart disease in middle-aged adults with diabetes. Diabetes Care 2003;26:2777-84.
27. Beulens JW, Monninkhof EM, Verschuren WM, et al. Cohort Profile: The EPIC-NL study. Int J Epidemiol 2009.
28. Boeing H, Korfmann A, Bergmann MM. Recruitment procedures of EPIC-Germany. European Investigation into Cancer and Nutrition. Ann Nutr Metab 1999;43:205-15.
29. Simons PC, Algra A, van de Laak MF, et al. Second manifestations of ARTerial disease (SMART) study: rationale and design. Eur J Epidemiol 1999;15:773-81.
30. Donders ART, van der Heijden GJMG, Stijnen T, et al. Review: a gentle introduction to imputation of missing values. J Clin Epidemiol 2006;59:1087-91.
31. Moons KG, Altman DG, Vergouwe Y, et al. Prognosis and prognostic research: application and impact of prognostic models in clinical practice. BMJ 2009;338: b606.
32. Kengne AP, Patel A, Colagiuri S, et al. The Framingham and UK Prospective Diabetes Study (UKPDS) risk equations do not reliably estimate the probability of cardiovascular events in a large ethnically diverse sample of patients with diabetes: the Action in Diabetes and Vascular Disease: Preterax and Diamicron-MR Controlled Evaluation (ADVANCE) Study. Diabetologia 2010;53:821-31.
33. van der Heijden AA, Ortegon MM, Niessen LW, et al. Prediction of coronary heart disease risk in a general, pre-diabetic, and diabetic population during 10 years of follow-up: accuracy of the Framingham, SCORE, and UKPDS risk functions: the Hoorn Study. Diabetes Care 2009;32:2094-8.
34. Cook NR. Use and misuse of the receiver operating characteristic curve in risk prediction. Circulation 2007;115:928-35.